Patent 9895444 was granted and assigned to Aegis Therapeutics on February, 2018 by the United States Patent and Trademark Office.
The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.